Adaptation des doses de médicament des conditionnements de greffe de cellules souches hématopoïétiques dans des populations avec comorbidité : obésité, maladie rénale chronique ou hépatopathie : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)-Reference-Cited by-同舟云学术

Adaptation des doses de médicament des conditionnements de greffe de cellules souches hématopoïétiques dans des populations avec comorbidité : obésité, maladie rénale chronique ou hépatopathie : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

Published:2017-12 Issue:12 Volume:104 Page:S99-S105
ISSN:0007-4551
Container-title:Bulletin du Cancer
language:fr
Short-container-title:Bulletin du Cancer

Author:

Simon Nicolas^ORCID,Coiteux Valérie,Bruno Bénédicte,Taque Sophie,Charbonnier Amandine,Souchet Laetitia,Vincent Laure,Yakoub-Agha Ibrahim,Chalandon Yves

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Reference28 articles.

1. Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation Practice Guideline Committee;Bubalo;Biol Blood Marrow Transplant,2014

2. Preparative regimen dosing for hematopoietic stem cell transplantation in patients with chronic hepatic impairment: analysis of the literature and recommendations;Bodge;Biol Blood Marrow Transplant,2014

3. Preparative regimen dosing for hematopoietic stem cell transplantation in patients with chronic kidney disease: analysis of the literature and recommendations;Bodge;Biol Blood Marrow Transplant,2014

4. Chemotherapy dose adjustment for obese patients undergoing hematopoietic stem cell transplantation: a survey on behalf of the acute leukemia working party of the European society for blood and marrow transplantation;Shem-Tov;Oncologist,2015

5. Appropriate chemotherapy dosing for obese adult patient with cancer: American Society Of Clinical Oncology Clinical Practice Guidelines;Griggs;J Clin Oncol,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT);Bone Marrow Transplantation;2024-09-13

2. Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT;Transplantation and Cellular Therapy;2023-12

3. Un outil d’adaptation individualisée des posologies de médicaments chez le patient adulte obèse;Therapies;2023-07

4. Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life—experience of the French Network;Bone Marrow Transplantation;2022-04-14

5. Der knochenmarktransplantierte Patient auf der Intensivstation;Medizinische Klinik - Intensivmedizin und Notfallmedizin;2021-02-09